Drug Profile
Vosilasarm - Ellipses Pharma
Alternative Names: EP-0062; RAD-140; Testolone - Radius HealthLatest Information Update: 09 Dec 2022
Price :
$50
*
At a glance
- Originator Radius
- Developer Radius Health Inc.
- Class Amines; Antineoplastics; Chlorobenzenes; Nitriles; Osteoporosis therapies; Oxadiazoles; Small molecules
- Mechanism of Action Selective androgen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II HER2 negative breast cancer
- Discontinued Osteoporosis; Sarcopenia
Most Recent Events
- 05 Dec 2022 Phase-I/II clinical trials in HER2-negative-breast-cancer (Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA (PO) (NCT05573126)
- 17 Oct 2022 Phase-I clinical trials in Breast cancer (Late-stage disease, Metastatic disease) in USA (PO)
- 10 Oct 2022 Ellipses Pharma plans a phase I/II trial for Breast cancer (Late-stage disease, Metastatic disease) in USA (PO) in December 2022 (NCT05573126)